APO Research
Talk to an analyst

APO RESEARCH · REPORT

Doxorubicin Hydrochloride API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Doxorubicin Hydrochloride API Industry Research Report 2026

29 December 2025123 pages

Choose your research edition.

Industry ResearchDoxorubicin Hydrochloride API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Doxorubicin Hydrochloride API Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Doxorubicin Hydrochloride API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Doxorubicin Hydrochloride API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Doxorubicin Hydrochloride API Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Doxorubicin Hydrochloride API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Doxorubicin Hydrochloride API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Doxorubicin Hydrochloride API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Doxorubicin Hydrochloride API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Doxorubicin Hydrochloride API include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Doxorubicin Hydrochloride API market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Doxorubicin Hydrochloride API.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Doxorubicin Hydrochloride API Market by Company

Intas Pharmaceuticals Ltd

Olon Spa

Sterling Biotech Ltd

Synbias Pharma Ag

Teva Pharmaceutical Industries Ltd

Meiji Seika Pharma Co Ltd

Microbiopharm Japan Co Ltd

Pharmacia And Upjohn Co

Boryung Pharmaceutical

Transo-Pharm Handels Gmbh

Dzd Heze Pharmaceutical Co Ltd

Zhejiang Hisun Pharmaceutical

Guangdong Lingnan Pharmaceutical

Doxorubicin Hydrochloride API Segment by Type

Purity≥98%

Purity<98%

Doxorubicin Hydrochloride API Segment by Application

Injection

Freeze-dried Powder Injection

Liposomal Injection

Doxorubicin Hydrochloride API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Doxorubicin Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Doxorubicin Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Doxorubicin Hydrochloride API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Doxorubicin Hydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Doxorubicin Hydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Doxorubicin Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Doxorubicin Hydrochloride API Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Doxorubicin Hydrochloride API Production Market Share by Manufacturers Table 7. Global Doxorubicin Hydrochloride API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Doxorubicin Hydrochloride API Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Doxorubicin Hydrochloride API Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Doxorubicin Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Doxorubicin Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Doxorubicin Hydrochloride API Manufacturers, Product Type & Application Table 13. Global Doxorubicin Hydrochloride API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Doxorubicin Hydrochloride API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Intas Pharmaceuticals Ltd Company Information Table 18. Intas Pharmaceuticals Ltd Business Overview Table 19. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Product Portfolio Table 21. Intas Pharmaceuticals Ltd Recent Development Table 22. Olon Spa Company Information Table 23. Olon Spa Business Overview Table 24. Olon Spa Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. Olon Spa Doxorubicin Hydrochloride API Product Portfolio Table 26. Olon Spa Recent Development Table 27. Sterling Biotech Ltd Company Information Table 28. Sterling Biotech Ltd Business Overview Table 29. Sterling Biotech Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Sterling Biotech Ltd Doxorubicin Hydrochloride API Product Portfolio Table 31. Sterling Biotech Ltd Recent Development Table 32. Synbias Pharma Ag Company Information Table 33. Synbias Pharma Ag Business Overview Table 34. Synbias Pharma Ag Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Synbias Pharma Ag Doxorubicin Hydrochloride API Product Portfolio Table 36. Synbias Pharma Ag Recent Development Table 37. Teva Pharmaceutical Industries Ltd Company Information Table 38. Teva Pharmaceutical Industries Ltd Business Overview Table 39. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Product Portfolio Table 41. Teva Pharmaceutical Industries Ltd Recent Development Table 42. Meiji Seika Pharma Co Ltd Company Information Table 43. Meiji Seika Pharma Co Ltd Business Overview Table 44. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Product Portfolio Table 46. Meiji Seika Pharma Co Ltd Recent Development Table 47. Microbiopharm Japan Co Ltd Company Information Table 48. Microbiopharm Japan Co Ltd Business Overview Table 49. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Product Portfolio Table 51. Microbiopharm Japan Co Ltd Recent Development Table 52. Pharmacia And Upjohn Co Company Information Table 53. Pharmacia And Upjohn Co Business Overview Table 54. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Product Portfolio Table 56. Pharmacia And Upjohn Co Recent Development Table 57. Boryung Pharmaceutical Company Information Table 58. Boryung Pharmaceutical Business Overview Table 59. Boryung Pharmaceutical Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Boryung Pharmaceutical Doxorubicin Hydrochloride API Product Portfolio Table 61. Boryung Pharmaceutical Recent Development Table 62. Transo-Pharm Handels Gmbh Company Information Table 63. Transo-Pharm Handels Gmbh Business Overview Table 64. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Product Portfolio Table 66. Transo-Pharm Handels Gmbh Recent Development Table 67. Dzd Heze Pharmaceutical Co Ltd Company Information Table 68. Dzd Heze Pharmaceutical Co Ltd Business Overview Table 69. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Product Portfolio Table 71. Dzd Heze Pharmaceutical Co Ltd Recent Development Table 72. Zhejiang Hisun Pharmaceutical Company Information Table 73. Zhejiang Hisun Pharmaceutical Business Overview Table 74. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Product Portfolio Table 76. Zhejiang Hisun Pharmaceutical Recent Development Table 77. Guangdong Lingnan Pharmaceutical Company Information Table 78. Guangdong Lingnan Pharmaceutical Business Overview Table 79. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Product Portfolio Table 81. Guangdong Lingnan Pharmaceutical Recent Development Table 82. Global Doxorubicin Hydrochloride API Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 83. Global Doxorubicin Hydrochloride API Production by Region (2021-2026) & (Tons) Table 84. Global Doxorubicin Hydrochloride API Production Market Share by Region (2021-2026) Table 85. Global Doxorubicin Hydrochloride API Production Forecast by Region (2027-2032) & (Tons) Table 86. Global Doxorubicin Hydrochloride API Production Market Share Forecast by Region (2027-2032) Table 87. Global Doxorubicin Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Global Doxorubicin Hydrochloride API Production Value by Region (2021-2026) & (US$ Million) Table 89. Global Doxorubicin Hydrochloride API Production Value Market Share by Region (2021-2026) Table 90. Global Doxorubicin Hydrochloride API Production Value Forecast by Region (2027-2032) & (US$ Million) Table 91. Global Doxorubicin Hydrochloride API Market Average Price (US$/Ton) by Region (2021-2026) Table 92. Global Doxorubicin Hydrochloride API Market Average Price (US$/Ton) by Region (2027-2032) Table 93. Global Doxorubicin Hydrochloride API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 94. Global Doxorubicin Hydrochloride API Consumption by Region (2021-2026) & (Tons) Table 95. Global Doxorubicin Hydrochloride API Consumption Market Share by Region (2021-2026) Table 96. Global Doxorubicin Hydrochloride API Forecasted Consumption by Region (2027-2032) & (Tons) Table 97. Global Doxorubicin Hydrochloride API Forecasted Consumption Market Share by Region (2027-2032) Table 98. North America Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 99. North America Doxorubicin Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 100. North America Doxorubicin Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 101. Europe Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 102. Europe Doxorubicin Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 103. Europe Doxorubicin Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 104. Asia Pacific Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 105. Asia Pacific Doxorubicin Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 106. Asia Pacific Doxorubicin Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 107. South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 108. South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 109. South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 110. Global Doxorubicin Hydrochloride API Production by Type (2021-2026) & (Tons) Table 111. Global Doxorubicin Hydrochloride API Production by Type (2027-2032) & (Tons) Table 112. Global Doxorubicin Hydrochloride API Production Market Share by Type (2021-2026) Table 113. Global Doxorubicin Hydrochloride API Production Market Share by Type (2027-2032) Table 114. Global Doxorubicin Hydrochloride API Production Value by Type (2021-2026) & (US$ Million) Table 115. Global Doxorubicin Hydrochloride API Production Value by Type (2027-2032) & (US$ Million) Table 116. Global Doxorubicin Hydrochloride API Production Value Market Share by Type (2021-2026) Table 117. Global Doxorubicin Hydrochloride API Production Value Market Share by Type (2027-2032) Table 118. Global Doxorubicin Hydrochloride API Price by Type (2021-2026) & (US$/Ton) Table 119. Global Doxorubicin Hydrochloride API Price by Type (2027-2032) & (US$/Ton) Table 120. Global Doxorubicin Hydrochloride API Production by Application (2021-2026) & (Tons) Table 121. Global Doxorubicin Hydrochloride API Production by Application (2027-2032) & (Tons) Table 122. Global Doxorubicin Hydrochloride API Production Market Share by Application (2021-2026) Table 123. Global Doxorubicin Hydrochloride API Production Market Share by Application (2027-2032) Table 124. Global Doxorubicin Hydrochloride API Production Value by Application (2021-2026) & (US$ Million) Table 125. Global Doxorubicin Hydrochloride API Production Value by Application (2027-2032) & (US$ Million) Table 126. Global Doxorubicin Hydrochloride API Production Value Market Share by Application (2021-2026) Table 127. Global Doxorubicin Hydrochloride API Production Value Market Share by Application (2027-2032) Table 128. Global Doxorubicin Hydrochloride API Price by Application (2021-2026) & (US$/Ton) Table 129. Global Doxorubicin Hydrochloride API Price by Application (2027-2032) & (US$/Ton) Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Doxorubicin Hydrochloride API Distributors List Table 133. Doxorubicin Hydrochloride API Customers List Table 134. Doxorubicin Hydrochloride API Industry Trends Table 135. Doxorubicin Hydrochloride API Industry Drivers Table 136. Doxorubicin Hydrochloride API Industry Restraints Table 137. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Doxorubicin Hydrochloride API Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Purity≥98% Product Image Figure 7. Purity<98% Product Image Figure 8. Injection Product Image Figure 9. Freeze-dried Powder Injection Product Image Figure 10. Liposomal Injection Product Image Figure 11. Global Doxorubicin Hydrochloride API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Doxorubicin Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 13. Global Doxorubicin Hydrochloride API Production Capacity (2021-2032) & (Tons) Figure 14. Global Doxorubicin Hydrochloride API Production (2021-2032) & (Tons) Figure 15. Global Doxorubicin Hydrochloride API Average Price (US$/Ton) & (2021-2032) Figure 16. Global Doxorubicin Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Doxorubicin Hydrochloride API Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Doxorubicin Hydrochloride API Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 20. Global Doxorubicin Hydrochloride API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Doxorubicin Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Doxorubicin Hydrochloride API Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Doxorubicin Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Doxorubicin Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Doxorubicin Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Doxorubicin Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Doxorubicin Hydrochloride API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Doxorubicin Hydrochloride API Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 30. North America Doxorubicin Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 31. United States Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 32. United States Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 33. Canada Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 34. Mexico Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. Europe Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Doxorubicin Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 37. Germany Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. France Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. U.K. Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Italy Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Russia Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Spain Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Netherlands Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Switzerland Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Sweden Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Poland Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Asia Pacific Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Doxorubicin Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 49. China Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Japan Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. South Korea Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. India Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Australia Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Taiwan Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Southeast Asia Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 58. Brazil Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Turkey Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. GCC Countries Doxorubicin Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Global Doxorubicin Hydrochloride API Production Market Share by Type (2021-2032) Figure 64. Global Doxorubicin Hydrochloride API Production Value Market Share by Type (2021-2032) Figure 65. Global Doxorubicin Hydrochloride API Price (US$/Ton) by Type (2021-2032) Figure 66. Global Doxorubicin Hydrochloride API Production Market Share by Application (2021-2032) Figure 67. Global Doxorubicin Hydrochloride API Production Value Market Share by Application (2021-2032) Figure 68. Global Doxorubicin Hydrochloride API Price (US$/Ton) by Application (2021-2032) Figure 69. Doxorubicin Hydrochloride API Value Chain Figure 70. Doxorubicin Hydrochloride API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Doxorubicin Hydrochloride API Industry Opportunities and Challenges

Scope & coverage.

Types
  • Purity≥98%
  • Purity<98%
Applications
  • Injection
  • Freeze-dried Powder Injection
  • Liposomal Injection
Companies covered
  • Intas Pharmaceuticals Ltd
  • Olon Spa
  • Sterling Biotech Ltd
  • Synbias Pharma Ag
  • Teva Pharmaceutical Industries Ltd
  • Meiji Seika Pharma Co Ltd
  • Microbiopharm Japan Co Ltd
  • Pharmacia And Upjohn Co
  • Boryung Pharmaceutical
  • Transo-Pharm Handels Gmbh
  • Dzd Heze Pharmaceutical Co Ltd
  • Zhejiang Hisun Pharmaceutical
  • Guangdong Lingnan Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Doxorubicin Hydrochloride API by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Purity≥98%
  5. 2.2.3 Purity<98%
  6. 2.3 Doxorubicin Hydrochloride API by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection
  9. 2.3.3 Freeze-dried Powder Injection
  10. 2.3.4 Liposomal Injection
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Doxorubicin Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Doxorubicin Hydrochloride API Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Doxorubicin Hydrochloride API Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Doxorubicin Hydrochloride API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Doxorubicin Hydrochloride API Production by Manufacturers (2021-2026)
  2. 3.2 Global Doxorubicin Hydrochloride API Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Doxorubicin Hydrochloride API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Doxorubicin Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Doxorubicin Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Doxorubicin Hydrochloride API Manufacturers, Product Type & Application
  7. 3.7 Global Doxorubicin Hydrochloride API Manufacturers Established Date
  8. 3.8 Global Doxorubicin Hydrochloride API Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Intas Pharmaceuticals Ltd
  2. 4.1.1 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Company Information
  3. 4.1.2 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Business Overview
  4. 4.1.3 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Intas Pharmaceuticals Ltd Product Portfolio
  6. 4.1.5 Intas Pharmaceuticals Ltd Recent Developments
  7. 4.2 Olon Spa
  8. 4.2.1 Olon Spa Doxorubicin Hydrochloride API Company Information
  9. 4.2.2 Olon Spa Doxorubicin Hydrochloride API Business Overview
  10. 4.2.3 Olon Spa Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Olon Spa Product Portfolio
  12. 4.2.5 Olon Spa Recent Developments
  13. 4.3 Sterling Biotech Ltd
  14. 4.3.1 Sterling Biotech Ltd Doxorubicin Hydrochloride API Company Information
  15. 4.3.2 Sterling Biotech Ltd Doxorubicin Hydrochloride API Business Overview
  16. 4.3.3 Sterling Biotech Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Sterling Biotech Ltd Product Portfolio
  18. 4.3.5 Sterling Biotech Ltd Recent Developments
  19. 4.4 Synbias Pharma Ag
  20. 4.4.1 Synbias Pharma Ag Doxorubicin Hydrochloride API Company Information
  21. 4.4.2 Synbias Pharma Ag Doxorubicin Hydrochloride API Business Overview
  22. 4.4.3 Synbias Pharma Ag Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Synbias Pharma Ag Product Portfolio
  24. 4.4.5 Synbias Pharma Ag Recent Developments
  25. 4.5 Teva Pharmaceutical Industries Ltd
  26. 4.5.1 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Company Information
  27. 4.5.2 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Business Overview
  28. 4.5.3 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Teva Pharmaceutical Industries Ltd Product Portfolio
  30. 4.5.5 Teva Pharmaceutical Industries Ltd Recent Developments
  31. 4.6 Meiji Seika Pharma Co Ltd
  32. 4.6.1 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Company Information
  33. 4.6.2 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Business Overview
  34. 4.6.3 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Meiji Seika Pharma Co Ltd Product Portfolio
  36. 4.6.5 Meiji Seika Pharma Co Ltd Recent Developments
  37. 4.7 Microbiopharm Japan Co Ltd
  38. 4.7.1 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Company Information
  39. 4.7.2 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Business Overview
  40. 4.7.3 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Microbiopharm Japan Co Ltd Product Portfolio
  42. 4.7.5 Microbiopharm Japan Co Ltd Recent Developments
  43. 4.8 Pharmacia And Upjohn Co
  44. 4.8.1 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Company Information
  45. 4.8.2 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Business Overview
  46. 4.8.3 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Pharmacia And Upjohn Co Product Portfolio
  48. 4.8.5 Pharmacia And Upjohn Co Recent Developments
  49. 4.9 Boryung Pharmaceutical
  50. 4.9.1 Boryung Pharmaceutical Doxorubicin Hydrochloride API Company Information
  51. 4.9.2 Boryung Pharmaceutical Doxorubicin Hydrochloride API Business Overview
  52. 4.9.3 Boryung Pharmaceutical Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Boryung Pharmaceutical Product Portfolio
  54. 4.9.5 Boryung Pharmaceutical Recent Developments
  55. 4.10 Transo-Pharm Handels Gmbh
  56. 4.10.1 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Company Information
  57. 4.10.2 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Business Overview
  58. 4.10.3 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Transo-Pharm Handels Gmbh Product Portfolio
  60. 4.10.5 Transo-Pharm Handels Gmbh Recent Developments
  61. 4.11 Dzd Heze Pharmaceutical Co Ltd
  62. 4.11.1 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Company Information
  63. 4.11.2 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Business Overview
  64. 4.11.3 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Dzd Heze Pharmaceutical Co Ltd Product Portfolio
  66. 4.11.5 Dzd Heze Pharmaceutical Co Ltd Recent Developments
  67. 4.12 Zhejiang Hisun Pharmaceutical
  68. 4.12.1 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Company Information
  69. 4.12.2 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Business Overview
  70. 4.12.3 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Zhejiang Hisun Pharmaceutical Product Portfolio
  72. 4.12.5 Zhejiang Hisun Pharmaceutical Recent Developments
  73. 4.13 Guangdong Lingnan Pharmaceutical
  74. 4.13.1 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Company Information
  75. 4.13.2 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Business Overview
  76. 4.13.3 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Guangdong Lingnan Pharmaceutical Product Portfolio
  78. 4.13.5 Guangdong Lingnan Pharmaceutical Recent Developments
5 Global Doxorubicin Hydrochloride API Production by Region
  1. 5.1 Global Doxorubicin Hydrochloride API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Doxorubicin Hydrochloride API Production by Region: 2021-2032
  3. 5.2.1 Global Doxorubicin Hydrochloride API Production by Region: 2021-2026
  4. 5.2.2 Global Doxorubicin Hydrochloride API Production Forecast by Region (2027-2032)
  5. 5.3 Global Doxorubicin Hydrochloride API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Doxorubicin Hydrochloride API Production Value by Region: 2021-2032
  7. 5.4.1 Global Doxorubicin Hydrochloride API Production Value by Region: 2021-2026
  8. 5.4.2 Global Doxorubicin Hydrochloride API Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Doxorubicin Hydrochloride API Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Doxorubicin Hydrochloride API Production and Value, YOY Growth
  11. 5.6.1 North America Doxorubicin Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Doxorubicin Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Doxorubicin Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Doxorubicin Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
6 Global Doxorubicin Hydrochloride API Consumption by Region
  1. 6.1 Global Doxorubicin Hydrochloride API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Doxorubicin Hydrochloride API Consumption by Region (2021-2032)
  3. 6.2.1 Global Doxorubicin Hydrochloride API Consumption by Region: 2021-2026
  4. 6.2.2 Global Doxorubicin Hydrochloride API Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Doxorubicin Hydrochloride API Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Doxorubicin Hydrochloride API Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Doxorubicin Hydrochloride API Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Doxorubicin Hydrochloride API Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Doxorubicin Hydrochloride API Production by Type (2021-2032)
  2. 7.1.1 Global Doxorubicin Hydrochloride API Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Doxorubicin Hydrochloride API Production Market Share by Type (2021-2032)
  4. 7.2 Global Doxorubicin Hydrochloride API Production Value by Type (2021-2032)
  5. 7.2.1 Global Doxorubicin Hydrochloride API Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Doxorubicin Hydrochloride API Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Doxorubicin Hydrochloride API Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Doxorubicin Hydrochloride API Production by Application (2021-2032)
  2. 8.1.1 Global Doxorubicin Hydrochloride API Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Doxorubicin Hydrochloride API Production Market Share by Application (2021-2032)
  4. 8.2 Global Doxorubicin Hydrochloride API Production Value by Application (2021-2032)
  5. 8.2.1 Global Doxorubicin Hydrochloride API Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Doxorubicin Hydrochloride API Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Doxorubicin Hydrochloride API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Doxorubicin Hydrochloride API Value Chain Analysis
  2. 9.1.1 Doxorubicin Hydrochloride API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Doxorubicin Hydrochloride API Production Mode & Process
  5. 9.2 Doxorubicin Hydrochloride API Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Doxorubicin Hydrochloride API Distributors
  8. 9.2.3 Doxorubicin Hydrochloride API Customers
10 Global Doxorubicin Hydrochloride API Analyzing Market Dynamics
  1. 10.1 Doxorubicin Hydrochloride API Industry Trends
  2. 10.2 Doxorubicin Hydrochloride API Industry Drivers
  3. 10.3 Doxorubicin Hydrochloride API Industry Opportunities and Challenges
  4. 10.4 Doxorubicin Hydrochloride API Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst